DOSSIER · 13F-HR · Q1 2026

SymBiosis Capital Partners, LLC

$53M in tracked AUM across 6 positions as of Q1 2026.

SC
CIK 0002006045 · last filed Mar 31, 2026
Total AUM
$53M
as of Q1 2026
Holdings
6
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

SymBiosis Capital Partners, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
EVMN
Evommune, Inc.
$29M1.3M55.8%
02
IVA
Inventiva S.A.
$13M2.4M24.8%
03
Y95308105
Wave Life Sciences Ltd.
$5M750K10.3%
04
RANI
Rani Therapeutics Holdings, Inc.
$3M3.7M5.1%
05
CLNN
Clene Nanomedicine Inc.
$2M431K4.0%
06
SRZNW
Surrozen, Inc.
$2K150K0.0%

Filing history

2026Q1Mar 31
$53M 51.8%
6 positionsView →
2025Q4Dec 31
$109M
11 positionsView →